Prostate Cancer Connect
  • Saved
Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification

Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification

Source : https://pubmed.ncbi.nlm.nih.gov/37679602/

Despite a lack of consensus for BCR treatment among guideline associations and medical societies, risk stratification of patients is essential for personalized treatment approaches, as it allows for an informed...

Despite a lack of consensus for BCR treatment among guideline associations and medical societies, risk stratification of patients is essential for personalized treatment approaches, as it allows for an informed selection of therapeutic strategies and estimation of adverse events.

  • Saved
Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis

Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis

Source : https://pubmed.ncbi.nlm.nih.gov/38768661/

Prostate cancer (PCa) is a global health concern, ranking as the most common cancer among men in Western countries. Traditional diagnostic methods are invasive with adverse effects on patients. Due...

Extracellular vesicles (EVs) show promise as biomarkers in liquid biopsy for prostate cancer (PCa), enhancing diagnosis and treatment monitoring. Metabolomics complements EV analysis, offering insights into PCa biomarkers, highlighting a robust approach for improving PCa management.

  • Saved
Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications

Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications

Source : https://pubmed.ncbi.nlm.nih.gov/38927984/

CtDNA is emerging as a non-invasive clinical detection method for several cancers, including genitourinary (GU) cancers such as prostate cancer, bladder cancer, and renal cell carcinoma (RCC). CtDNA assays have...

The use of ctDNA in GU cancers has multi-faceted applications and a promising future. Early detection and screening remain a significant unmet need in GU cancers, and meeting this need holds great potential to reduce cancer-related mortality and morbidity. As screening methods for GU cancers are widely debated or non-existent, ctDNA will...

  • Saved
Elastography of the Male Pelvic Region-Perspectives on Malignant Lesions

Elastography of the Male Pelvic Region-Perspectives on Malignant Lesions

Source : https://pubmed.ncbi.nlm.nih.gov/38928634/

Ultrasound elastography is widely used to assess tissue stiffness for lesion characterization, including differentiation between benign and malignant lesions. This study focuses on the use of elastography in the male...

Elastography is a technique that evaluates organ tissue either in a colour-coded map or through an objective quantitative value. Most ultrasound machines include elastography as a standard tool, providing high diagnostic accuracy when a multi-US imaging approach is used to evaluate the tissue. The recent diagnostic advancement of elastography...

  • Saved
Prostate Adenocarcinoma with Signet-Ring Cells and Features of Mucin: A Clinical Case and Literature Review

Prostate Adenocarcinoma with Signet-Ring Cells and Features of Mucin: A Clinical Case and Literature Review

Source : https://pubmed.ncbi.nlm.nih.gov/38929494/

Introduction : Signet-ring cells are typically associated with mucin-secreting epithelium; thus, they are most commonly found in the gastrointestinal tract, but not exclusively. Primary signet-ring cell carcinoma of the prostate...

This clinical case highlights the importance of a multidisciplinary approach in conducting comprehensive diagnostic studies that unfortunately remain unstandardized to this day. The rarity of the entity together with the late diagnosis poses a great challenge in choosing an appropriate treatment to improve the prognosis.